PhoenixBio Co (TSE:6190) Beginning Cash Position: 円0 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TSE:6190 PhoenixBio Co Ltd TSE:6190
56 GF Score
Price 円341.00
GF Value 円362.72
Valuation Fairly Valued
! 3 Warning Signs
View Full Analysis

What is PhoenixBio Co Beginning Cash Position?

PhoenixBio Co TSE:6190 +0.29% 56 Beginning Cash Position is 円0 Mil as of Mar. 2026. GuruFocus rates TSE:6190 with a GF Score™ of 56/100 and a GF Value™ of 円362.72 (Fairly Valued). The stock has 3 warning signs investors should review.

PhoenixBio Co's Beginning Cash Position for the quarter that ended in Mar. 2026 was 円0 Mil.

PhoenixBio Co's annual Beginning Cash Position declined from Mar. 2024 (円1,555 Mil) to Mar. 2025 (円1,385 Mil) and declined from Mar. 2025 (円1,385 Mil) to Mar. 2026 (円1,149 Mil).

PhoenixBio Co Beginning Cash Position Related Terms

PhoenixBio Co Beginning Cash Position Historical Data

* Premium members only.

The historical data trend for PhoenixBio Co's Beginning Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

PhoenixBio Co Beginning Cash Position Chart

PhoenixBio Co Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Beginning Cash Position
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1,327.81 1,325.51 1,555.32 1,384.89 1,149.39

PhoenixBio Co Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Beginning Cash Position Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
TSE:6190
56GF Score
PhoenixBio Co Ltd TSE:6190
Beginning Cash Position is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

PhoenixBio Co Beginning Cash Position Calculation

Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement.

What does a Beginning Cash Position of 円0 Mil mean?
PhoenixBio Co (TSE:6190) has a Beginning Cash Position of 円0 Mil as of Mar. 2026. Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement. View historical data on PhoenixBio Co and its competitors.
Is PhoenixBio Co's Beginning Cash Position too high?
PhoenixBio Co's current Beginning Cash Position is 円0 Mil. Overall, PhoenixBio Co has a GF Score™ of 56/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does PhoenixBio Co's Beginning Cash Position compare to VRTX and REGN?
PhoenixBio Co's Beginning Cash Position of 円0 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Beginning Cash Position for a Biotechnology company?
A good Beginning Cash Position depends on the Biotechnology industry context. However, Beginning Cash Position should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Beginning Cash Position mean?
A high Beginning Cash Position can signal that a stock is expensive relative to its fundamentals. Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement. View historical data on PhoenixBio Co and its competitors. PhoenixBio Co's current Beginning Cash Position is 円0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PhoenixBio Co stock overvalued right now?
Based on GuruFocus' analysis, PhoenixBio Co (TSE:6190) is currently considered Fairly Valued. The stock's GF Value™ is 円362.72, compared to a current price of 円341.00 — trading 6% below its estimated fair value. The current Beginning Cash Position is 円0 Mil. PhoenixBio Co's overall GF Score™ is 56/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Beginning Cash Position calculated?
Beginning Cash Position is calculated from a company's financial statements. For PhoenixBio Co (TSE:6190), the current Beginning Cash Position is 円0 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is PhoenixBio Co (TSE:6190) Overvalued in 2026?

Based on GuruFocus' analysis, PhoenixBio Co stock appears to be undervalued. The current stock price of 円341.00 is trading 6% below its estimated GF Value™ of 円362.72. GuruFocus considers PhoenixBio Co to be Fairly Valued.

Key valuation signals for TSE:6190:

  • Beginning Cash Position: 円0 Mil
  • GF Value™: 円362.72 vs. price of 円341.00 (6% below fair value)
  • GF Score™: 56/100 with 3 warning signs

No single metric tells the full story. See the TSE:6190 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

PhoenixBio Co Business Description

Address 3-4-1, Kagamiyama, Hiroshima Prefecture, Higashi-Hiroshima, JPN, 739-0046
PhoenixBio Co Ltd conducts study services for drug discovery and early development. It provides outsourcing services for drug development. The Company uses PXB-Mouse to conduct the study. Its services include pharmacokinetics-related tests, safety tests, and hepatitis virus (HBV / HCV) related drug efficacy tests. Geographically, the company generates the majority of its revenue from USA.
56GF Score

Get the complete analysis for TSE:6190

Beginning Cash Position is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円341.00
Price
円362.72
GF Value